National Natural Science Foundation of China(Nos.82304708 and U23A20511);the CAMS Innovation Fund for Medical Sciences(2023-I2M-QJ-013,2021-I2M-1-031,2022-I2M-2-002,and 2023-I2M-3-006,China);the Beijing Natural Science Foundation(No.Z220019,China).
Non-alcoholic fatty liver disease(NAFLD),characterized by hepatic steatosis,is a common metabolic liver disease worldwide.Currently,satisfactory drugs for NAFLD treatment remain lacking.Obesity and diabetes are the le...
Supported by Basic and Applied Basic Research Found of Guangdong Province,No.2022A1515011307。
BACKGROUND Fanlian Huazhuo Formula(FLHZF)has the functions of invigorating spleen and resolving phlegm,clearing heat and purging turbidity.It has been identified to have therapeutic effects on type 2 diabetes mellitus...